see fast-acting results that gradually soften over time*
DAXXIFY® before and after
*In clinical trial diaries, patients reported seeing a measurable improvement within 2 days of treatment. 74% achieved a ≥ 2-grade improvement at week 4 per both physician's and patient’s assessment. More than 50% had no or minor frown lines until 6 months after treatment per both physician's and patient's assessments.
Real DAXXIFY® patient.
Results may vary.
Three benefits.
One unique formula.
Fast-acting
DAXXIFY® kicks in quickly. Most users see results as early as the next day and typically within two days after treatment.*
Long-lasting
DAXXIFY® is long-lasting and keeps frown lines smoother with results that slowly soften over a prolonged period.†
Radiant-looking results
Improves the appearance of skin texture after treatment, smoothing even the deepest lines.‡
The most common side effects of DAXXIFY® include headache, eyelid drooping, and loss of ability to move the muscles in your face.
*In clinical trial diaries, patients reported seeing a measurable improvement within 2 days of treatment.
†More than 50% had no or minor frown lines until 6 months after treatment per both physician's and patient's assessments. 74% achieved a ≥ 2-grade improvement at week 4 per both physician's and patient’s assessment.
‡In an open label study (N=27), 96% of patients agreed their skin looked smooth in the glabella (exploratory endpoint).
Ditch the default with DAXXIFY®
The difference is in the peptide formulation.
*In clinical trial diaries, patients reported seeing a measurable improvement within 2 days of treatment. 74% achieved a ≥ 2-grade improvement at week 4 per both physician's and patient’s assessment. More than 50% had no or minor frown lines until 6 months after treatment per both physician's and patient's assessments. In an open label study (N=27), 96% of patients agreed their skin looked smooth in the glabella (exploratory endpoint).
Ready to take the next step?
Find a provider.
FIND DAXXIFY®
Want to learn more?
Discover the difference